Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells
- 1 October 1997
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 27 (10) , 1167-1174
- https://doi.org/10.1111/j.1365-2222.1997.tb01154.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cellsAllergy, 1995
- C5a-induced expression of P-selectin in endothelial cells.Journal of Clinical Investigation, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- IL-6 induces hepatic inflammation and collagen synthesisin vivoClinical and Experimental Immunology, 1994
- Inhibitory Effect of the H1 Antagonist Loratadine on Histamine Release from Human BasophilsInternational Archives of Allergy and Immunology, 1994
- Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist.Journal of Clinical Investigation, 1993
- Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individualsJournal of Allergy and Clinical Immunology, 1992
- Suppresive effect of loratadine on allergen‐induced histamine release in the noseAllergy, 1991
- Antiallergic activity of H-receptor antagonists assessed by nasal challengeJournal of Allergy and Clinical Immunology, 1988
- Inflammatory mediators and mechanisms of release from purified human basophils and mast cellsJournal of Allergy and Clinical Immunology, 1984